Article

A new home for Ira Ross Eye Institute

Buffalo, NY-The University of Buffalo's (UB) Ira G. Ross Eye Institute's new home, which is a collaboration of the department of ophthalmology in UB's School of Medicine and Biomedical Sciences, the Elizabeth Pierce Olmsted, MD, Center for the Visually Impaired and University Ophthalmology Services opened at 1176 Main Street.

Buffalo, NY-The University of Buffalo's (UB) Ira G. Ross Eye Institute's new home, which is a collaboration of the department of ophthalmology in UB's School of Medicine and Biomedical Sciences, the Elizabeth Pierce Olmsted, MD, Center for the Visually Impaired and University Ophthalmology Services opened at 1176 Main Street.

As an important part of the university's major initiative to create a more apparent presence in downtown Buffalo, the institute is located on the Buffalo Niagara Medical Campus.

Diagnosis and treatment of adults and children with diseases of the eye and vision system takes place at the institute. The research component takes place on UB's south campus; patient care and training of physicians takes place at 1176 Main Street. The adjacent Olmsted Center provides vision services, rehabilitation, job training, and social services for those with visual disability.

The unique aspect about this institute is that it can meet the needs of the visually impaired "from cradle to grave" at one location.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.